AU518375B2 - Ester of mm4550, mm13902 and mm17880 - Google Patents

Ester of mm4550, mm13902 and mm17880

Info

Publication number
AU518375B2
AU518375B2 AU27986/77A AU2798677A AU518375B2 AU 518375 B2 AU518375 B2 AU 518375B2 AU 27986/77 A AU27986/77 A AU 27986/77A AU 2798677 A AU2798677 A AU 2798677A AU 518375 B2 AU518375 B2 AU 518375B2
Authority
AU
Australia
Prior art keywords
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU27986/77A
Other versions
AU2798677A (en
Inventor
D. F. and Eglington A. J Corbett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of AU2798677A publication Critical patent/AU2798677A/en
Application granted granted Critical
Publication of AU518375B2 publication Critical patent/AU518375B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5456Arylalkanephosphonium compounds
AU27986/77A 1976-08-17 1977-08-17 Ester of mm4550, mm13902 and mm17880 Expired AU518375B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB34106/76A GB1531141A (en) 1976-08-17 1976-08-17 Beta-lactam antibiotics
GBGB34106/76 1976-08-17

Publications (2)

Publication Number Publication Date
AU2798677A AU2798677A (en) 1979-02-22
AU518375B2 true AU518375B2 (en) 1981-10-01

Family

ID=10361448

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27986/77A Expired AU518375B2 (en) 1976-08-17 1977-08-17 Ester of mm4550, mm13902 and mm17880

Country Status (19)

Country Link
JP (1) JPS5323995A (en)
AT (1) AT351678B (en)
AU (1) AU518375B2 (en)
BE (1) BE857781A (en)
CA (1) CA1104139A (en)
CH (1) CH639664A5 (en)
DE (1) DE2736482A1 (en)
DK (1) DK364177A (en)
ES (1) ES461691A1 (en)
FI (1) FI772432A (en)
FR (2) FR2362142A1 (en)
GB (1) GB1531141A (en)
IE (1) IE45559B1 (en)
IL (1) IL52638A (en)
NL (1) NL7709007A (en)
NZ (1) NZ184808A (en)
PT (1) PT66882B (en)
SE (1) SE7709071L (en)
ZA (1) ZA774703B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002564B1 (en) * 1977-11-12 1984-06-20 Beecham Group Plc Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
EP0004132A1 (en) * 1978-03-04 1979-09-19 Beecham Group Plc Esters of beta-lactam antibiotics, a process for their preparation pharmaceutical compositions containing them and the compounds for use as antibacterial agents
US4446146A (en) * 1978-07-26 1984-05-01 Beecham Group Limited β-Lactam containing compounds, their preparation and use
EP0007753B1 (en) * 1978-08-02 1982-08-25 Beecham Group Plc Beta-lactam antibacterial agents, a process for their preparation and pharmaceutical compositions containing them
US4530791A (en) * 1979-04-16 1985-07-23 Kowa Co., Ltd. β-Lactam antibiotics
EP0024832B1 (en) * 1979-08-10 1985-03-13 Beecham Group Plc Beta-lactam antibiotics, their preparation, pharmaceutical compositions containing them and their preparation
EP0044142A1 (en) * 1980-07-03 1982-01-20 Beecham Group Plc Process for the preparation of beta-lactam antibiotics
EP0057565A1 (en) * 1981-02-04 1982-08-11 Beecham Group Plc Beta-lactam antibiotics, their preparation and use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633554A5 (en) * 1975-11-21 1982-12-15 Merck & Co Inc Process for the preparation of novel thienamycin derivatives.

Also Published As

Publication number Publication date
CH639664A5 (en) 1983-11-30
FI772432A (en) 1978-02-18
IE45559B1 (en) 1982-09-22
AT351678B (en) 1979-08-10
BE857781A (en) 1978-02-13
CA1104139A (en) 1981-06-30
ZA774703B (en) 1978-06-28
ES461691A1 (en) 1978-06-01
SE7709071A0 (en) 1978-02-17
FR2405260A1 (en) 1979-05-04
IL52638A (en) 1980-12-31
DE2736482A1 (en) 1978-02-23
DK364177A (en) 1978-02-18
PT66882A (en) 1977-09-01
ATA592177A (en) 1979-01-15
SE7709071L (en) 1978-02-17
NZ184808A (en) 1980-04-28
FR2362142B1 (en) 1981-11-06
IE45559L (en) 1978-02-17
NL7709007A (en) 1978-02-21
JPS5323995A (en) 1978-03-06
IL52638A0 (en) 1977-10-31
FR2362142A1 (en) 1978-03-17
PT66882B (en) 1979-01-24
AU2798677A (en) 1979-02-22
FR2405260B1 (en) 1980-10-31
GB1531141A (en) 1978-11-01

Similar Documents

Publication Publication Date Title
AU514849B2 (en) Composition and process
AU512223B2 (en) 15-Deoxy-16-hydroxy-16-substituted postanoic acids and congeners
AU512626B2 (en) 4-Hydroxyphenylalkanolamine derivatives and preparation thereof
AU509070B2 (en) Compander
AU508835B2 (en) Compander
AU507801B2 (en) Olefinpoylmerization and Catalyst
AU518375B2 (en) Ester of mm4550, mm13902 and mm17880
AU508938B2 (en) Hydroxymethyl-pyridine esters
AU2219977A (en) Preparation of 7-alkoxy-3-chloromethylcephems
AU518148B2 (en) Esters w phenylethylahines
AU512322B2 (en) Derivatives of 2-phenyl-2-hydroxyethylamine
AU497882B2 (en) B-phenyl-4-piperidinores and dihydropyridinones
AU518954B2 (en) Derivatives of 9-chloroprednisolone
AU549876B2 (en) Dihydrocyclosporin d and isocyclosporin d
AU503391B2 (en) Thienothienylcarbonyl-phenyakanoic acids and derivatives
AU497510B2 (en) Reduction of friction
AU516174B2 (en) D-homosteroids and pharmaceuticals
AU518500B2 (en) Anhydro-sugars and pharmaceuticals
AU520966B2 (en) N-phosphonoacetyl-l-aspartic and derivatives
AU507702B2 (en) Trans-octahydro-pyrido-benzazepine-3-alkanols-alkanonitriles,-alkanic acid and ester astranquilizer
AU486355B2 (en) 2-nitro-4-phenylsulfinylaniline and 2-nitro-4-phenylsulfinylacetanilide
AU2339777A (en) Preparation of hexachlorocyclobutene
AU505330B2 (en) Triazolylbenzophenones and triazolobenzodiazepines
AU489544B2 (en) Butyramides and butyrates
AU482216B2 (en) Composition and process